TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $395,000 | -2.7% | 28,129 | -0.7% | 0.03% | +12.0% |
| Q1 2022 | $406,000 | +88.8% | 28,335 | +80.2% | 0.02% | +92.3% |
| Q4 2021 | $215,000 | -51.6% | 15,727 | -41.9% | 0.01% | -56.7% |
| Q3 2021 | $444,000 | +0.2% | 27,087 | +2.9% | 0.03% | +3.4% |
| Q2 2021 | $443,000 | -7.1% | 26,326 | +0.8% | 0.03% | -14.7% |
| Q1 2021 | $477,000 | +11.4% | 26,115 | +11.0% | 0.03% | +6.2% |
| Q4 2020 | $428,000 | -23.6% | 23,526 | -25.1% | 0.03% | -33.3% |
| Q3 2020 | $560,000 | +31.8% | 31,405 | +32.5% | 0.05% | +20.0% |
| Q2 2020 | $425,000 | +100.5% | 23,697 | +69.0% | 0.04% | +53.8% |
| Q1 2020 | $212,000 | -17.2% | 14,019 | +9.6% | 0.03% | 0.0% |
| Q4 2019 | $256,000 | +12.3% | 12,795 | +14.1% | 0.03% | -10.3% |
| Q1 2019 | $228,000 | – | 11,214 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |